多发性硬化患者脑内钆潴留:线性和大环状钆基对比剂的MRI弛豫测量研究
该研究对85例多发性硬化患者和21名健康对照行纵向和横向弛豫率(R1、R2)测量,按既往钆基对比剂类型分为线性、混合和大环状组。线性钆基对比剂组齿状核、苍白球、尾状核和丘脑R1升高,苍白球和尾状核R2升高,且线性钆基对比剂给药次数与R1、R2升高相关,大环状组无此差异。部分区域弛豫率升高与信息处理速度降低和言语流畅性下降相关,但与躯体残疾或疲劳无关。
要点
- 线性钆基对比剂组齿状核、苍白球、尾状核和丘脑R1升高,苍白球和尾状核R2升高。
- 线性钆基对比剂给药次数与所有区域R1升高相关(丘脑R2除外),呈剂量依赖。
- 大环状钆基对比剂组未见类似差异和关联。
核心结论
- 既往线性而非大环状钆基对比剂给药与脑内弛豫率升高呈剂量依赖相关,部分区域弛豫率升高与认知障碍相关,但与躯体残疾或疲劳无关。
研究设计与样本
- 85例多发性硬化患者和21名健康对照行纵向和横向弛豫率(R1和R2)弛豫测量,患者按既往钆基对比剂给药分为线性、混合和大环状组,53例患者行神经心理测试,手动分割齿状核、苍白球、尾状核和丘脑,并行重复性测量。
关键影像表现/征象
- 线性钆基对比剂组齿状核、苍白球、尾状核和丘脑R1高于对照组。
- 线性钆基对比剂组苍白球和尾状核R2高于对照组。
- 大环状组未见类似差异。
诊断标准与关键数值
- 弛豫测量重复性稳健,扫描-再扫描差异为2.0%。
- 线性钆基对比剂给药次数与所有区域R1和R2升高相关(丘脑R2除外)。
- 较高弛豫率与较低信息处理速度(齿状核、丘脑)和言语流畅性(尾状核、丘脑)相关。
局限性
- 原文结论指出这些发现应谨慎解读,并鼓励进一步研究钆潴留与认知的关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Brain gadolinium retention is consistently reported for linear gadolinium-based contrast agents, while the results for macrocyclics are contradictory and potential clinical manifestations remain controversial. Furthermore, most previous studies are based on conventional T1-weighted MR imaging. We therefore aimed to quantitatively investigate longitudinal and transversal relaxation in the brain in relation to previous gadolinium-based contrast agent administration and explore associations with disability in multiple sclerosis.
MATERIALS AND METHODS: Eighty-five patients with MS and 21 healthy controls underwent longitudinal and transverse relaxation rate (R1 and R2) relaxometry. Patients were divided into linear, mixed, and macrocyclic groups based on previous gadolinium-based contrast agent administration. Neuropsychological testing was performed in 53 patients. The dentate nucleus, globus pallidus, caudate nucleus, and thalamus were manually segmented. Repeatability measures were also performed.
RESULTS: The relaxometry was robust (2.0% scan-rescan difference) and detected higher R1 (dentate nucleus, globus pallidus, caudate nucleus, thalamus) and R2 (globus pallidus, caudate nucleus) in patients receiving linear gadolinium-based contrast agents compared with controls. The number of linear gadolinium-based contrast agent administrations was associated with higher R1 and R2 in all regions (except R2 in the thalamus). No similar differences and associations were found for the macrocyclic group. Higher relaxation was associated with lower information-processing speed (dentate nucleus, thalamus) and verbal fluency (caudate nucleus, thalamus). No associations were found with physical disability or fatigue.
CONCLUSIONS: Previous linear, but not macrocyclic, gadolinium-based contrast agent administration is associated with higher relaxation rates in a dose-dependent manner. Higher relaxation in some regions is associated with cognitive impairment but not physical disability or fatigue in MS. The findings should be interpreted with care but encourage studies into gadolinium retention and cognition.
引用
- Forslin Y, Martola J, Bergendal Å, et al. Gadolinium Retention in the Brain: An MRI Relaxometry Study of Linear and Macrocyclic Gadolinium-Based Contrast Agents in Multiple Sclerosis. AJNR Am J Neuroradiol. 2019. PMID: 31248867. doi:10.3174/ajnr.A6112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。